Your browser doesn't support javascript.
loading
Fungal infection frequency in newly diagnosed acute myeloid leukaemia patients treated with venetoclax plus azacitidine with or without antifungal prophylaxis.
Weinbergerová, Barbora; Mayer, Jirí; Kabut, Tomás; Sperr, Wolfgang R; Stevková, Jana; Jonásová, Anna; Cernan, Martin; Herndlhofer, Susanne; Oravcová, Iveta; Srámek, Jirí; Novák, Jan; Stepánová, Radka; Szotkowski, Tomás; Drgona, Lubos; Zák, Pavel; Valent, Peter.
Afiliação
  • Weinbergerová B; Department of Internal Medicine - Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Mayer J; Department of Internal Medicine - Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Kabut T; Department of Internal Medicine - Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Sperr WR; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Stevková J; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Jonásová A; 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
  • Cernan M; Medical Department, Hematology, Charles University General Hospital, Prague, Czech Republic.
  • Herndlhofer S; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
  • Oravcová I; Division of Hematology and Hemostaseology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.
  • Srámek J; Department of Oncohematology, Comenius University and National Cancer Institute, Bratislava, Slovakia.
  • Novák J; Department of Haematology and Oncology, University Hospital Pilsen, Pilsen, Czech Republic.
  • Stepánová R; Department of Haematology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
  • Szotkowski T; Faculty of Medicine, Center of Excellence CREATIC, Masaryk University, Brno, Czech Republic.
  • Drgona L; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacký University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic.
  • Zák P; Department of Oncohematology, Comenius University and National Cancer Institute, Bratislava, Slovakia.
  • Valent P; 4th Department of Internal Medicine-Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Br J Haematol ; 2024 Jul 23.
Article em En | MEDLINE | ID: mdl-39044120
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Haematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: República Tcheca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Br J Haematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: República Tcheca